Covid 19 Outbreak | Autoinjectors Market | Opportunities, Key Players, Competitive and Regional Analysis by Forecast 2023

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs.

What the Autoinjectors Market Looks Like?

MarketsandMarkets forecasts Autoinjectors market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2%. North America to witness the highest market growth during the forecast period.

Growth in the global autoinjectors market is mainly driven by factors such as the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements in autoinjector devices. The patent expiry of biologics in the coming years is also expected to provide growth opportunities for players in the autoinjectors market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724

What Drives the Autoinjectors Market?

The growth of the global market for Autoinjectors Market is primarily influenced by the following factors:

• Growing Prevalence of Targeted Therapies
• Rising Incidence of Anaphylaxis
• Increasing Number of Regulatory Approvals
• Availability of Generic Versions of Autoinjectors
• Favorable Reimbursements and Government Support
• Technological Advancements and Design Development

Disposable autoinjectors are the most-preferred autoinjectors due to their ease of use and the presence of a built-in glass syringe (eliminates the need for manually loading the glass syringe), which makes it more convenient for patients with reduced dexterity or visual impairments.

A majority of autoinjectors are used for self-administration of drugs and are rarely recommended for hospital use to avoid the risk of infection due to use on multiple patients. This is a major factor in driving the market growth. Other factors such as the growing prevalence of chronic diseases and technological advancements are also boosting this market segment.

Recent Developments :

• In 2018, Abbvie and Samsung Bioepis signed a licensing agreement to launch Humira biosimilar in Europe.
• In 2018, Amgen collaborated with Simcere to co-develop and commercialize biosimilars in China.
• In 2018, Haselmeier partnered with Common Sensing to develop self-monitoring injector platforms, which will help patients to record the time and amount of every dose.
• In 2017, Ypsomed opened a new manufacturing facility in Solothurn (Switzerland). This new facility will focus on the production of injection systems.
• In 2017, Johnson & Johnson received FDA approval of SIMPONI for the treatment of adults with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS).

Geographical growth scenario of Autoinjectors Market :
The large share of the North American autoinjectors market can primarily be attributed to the rising prevalence of autoimmune and chronic diseases, increasing prevalence of anaphylaxis, and the increasing number of FDA approvals in the region.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724

Leading market players and strategies adopted

The prominent players in the Autoinjectors market are SHL Group, Becton Dickinson and Company, Ypsomed, Owen Mumford, Haselmeier

Particle Therapy Market | APAC Market is Expected to Grow at the Fastest Rate

Growth in the particle therapy market is primarily driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.

The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.

Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) – Forecast to 2023

What Drives the Market?

1. Advantages Offered By Particle Therapy Over Photon Therapy
2. Growing Global Prevalence of Cancer
4. Growing Adoption of Particle Therapy in Clinical Trials
5. Increasing Number of Particle Therapy Centers Worldwide

The study involved four major activities to estimate the current market size for particle therapy. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Synchrotrons are used to accelerate both protons and heavy ions such as carbon and hydrogen. The growth of the synchrotrons segment is attributed to factors such as the increasing number of research activities as well as the increasing investments in the development of synchrotron facilities.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137

The introduction of small footprint single-room particle therapy centers is further promoting the adoption of proton therapy for the treatment of cancer in small-scale hospitals. Factors driving the growth of the treatment applications segment include the growing number of cancer patients globally, increasing government initiatives (aimed at equipping or upgrading hospitals with newer and advanced Radiotherapy systems), and the increasing availability of funding for the adoption of advanced cancer treatment technologies.

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific (APAC)
4. Rest of the World

The Asia Pacific is one of the major revenue generating regions in the particle therapy market. China and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries.

Some key players mentioned in the research report are:

Key players in this particle therapy market include Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), and Hitachi, Ltd. (Japan) are the major players operating in the particle therapy market. Other players in this market include Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), ProTom International, Inc. (US), Advanced Oncotherapy Plc. (UK), and Danfysik A/S (Denmark).

Request Sample Report of particle therapy market @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137

Growth of Analytical Laboratory Services Market in North America, Europe, Asia Pacific and Rest of the World (RoW)

The overall market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services.

• The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period.

What Drives the Market?

1. Growing Expenditure on Drugs and Medical Devices By Public Organizations
2. Government Initiatives to Strengthen Analytical Testing Capabilities
3. Increasing Number of Drug Approvals and Clinical Trials
4. Rising Demand for Specialized Analytical Testing Services

The key trends for increase in market, by public health organization are the growing expenditure on drugs and medical devices by public health organizations, steps by the government to build up strong analytical testing abilities, increasing number of drug approvals and clinical trials, and rising demand for specialized analytical testing services.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65590498

On the basis of type of service, the spend assessment is segmented into eight segments, namely, bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing, and environmental monitoring. In 2015, the bioanalytical testing segment accounted for the largest share of the analytical laboratory services market, by public health organization. This growth can be attributed to factors such as the usage and development of a large number of macromolecules and Biosimilars for various therapeutic areas and the growing biopharmaceutical industry across the globe.

Target Audience :

• Government Agencies
• Nonprofit Organizations
• Analytical Laboratories
• Private Analytical Testing Providers

Scope of the Report:

The research report categorizes the market, by public health organization into the following segments:

Global Analytical Laboratory Services Market, By Public Health Organization, by Type of Service

• Bioanalytical Testing
• Batch Release Testing
• Stability Testing
• Raw Material Testing
• Physical Characterization
• Method Validation
• Microbial Testing
• Environmental Monitoring

Request Sample Pages :  https://www.marketsandmarkets.com/requestsampleNew.asp?id=65590498

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

Analytical Laboratory Services Market, by public health organization is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America commanded the largest share, followed by Europe, Asia-Pacific, and the RoW. The major share of this region can be attributed to the high expenditure on quality testing, strong regulatory scenario, increasing number of clinical trials, and the well-established federal testing laboratories in the region.

Some key players mentioned in the research report are:

Food and Drug Administration (U.S.), European Medicines Agency (U.K.), Federal Institute for Drugs and Medical Devices (Germany), Agence française de sécurité sanitaire des produits de santé (France), Agenzia Italiana del Farmaco (Italy), the Spanish Medicines and Health Products Agency (Spain), Central Drugs Standard Control Organization (India), China Food and Drug Administration, and Pharmaceuticals and Medical Devices Agency (Japan).

To get a 10% Customization on the report, click @https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=65590498

Global Infectious Disease Diagnostics Market Worth $19.35 Billion | Segmentation & Geographical Analysis

According to the new market research report “Infectious Disease Diagnostics Market by Product & Service (Assay, Kit & Reagent, Instruments), Disease Type (Hepatitis, HIV, HAI, HPV, TB, Influenza), Technology (Immunodiagnostics, PCR, NGS), End User (Hospital, Research Institute) – Global Forecast to 2022” published by MarketsandMarkets™

The global infectious disease diagnostics market was valued at USD 13.93 Billion in 2016 and projected to reach USD 19.35 Billion in 2022, at a CAGR of 5.6%.

What Drives the Market?

1. Increasing global prevalence of infectious diseases
2. Shift in focus from centralized laboratories to decentralized point-of-care testing
3. Growth in funding for research on infectious disease diagnostics

The global prevalence of infectious diseases such as influenza, HPV, hepatitis, HIV, and tuberculosis is considerably high in spite of significant improvements in sanitation practices and medicine. Many of the currently available diagnostic techniques are slow, involve complex procedures, and lack specific identification of causative agents.

Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=116764589

By product and service, assays, kits and reagents segment to record the highest CAGR during the forecast period

Increased accessibility and the increasing number of IDD tests conducted are the key drivers for this segment. Globally, the volume of IDD tests is increasing mainly due to the rising geriatric population; increasing prevalence of infectious diseases; increased variety of reagents available and analytical techniques employed; and the continuous launch of newer, faster, and more reliable products.

Roche, Bio-Rad, and bioMérieux are some of the major players in the infectious disease diagnostics market for assays, kits, & reagents.

On the basis of disease type, the infectious disease diagnostics (IDD) market is segmented into a wide range of diseases. Hospital acquired infections (HAI) segment to record the highest CAGR during the forecast period. Growth in HAI segment can be attributed to the rising burden of MRSA infections, the increasing number of new products launched in the market, and increasing adoption of technologically advanced HAI diagnostic tests such as BD MAX Cdiff assay, Xpert MRSA NxG, and ARIES C. difficile Assay that are based on PCR technology

Early buyers will receive 10% customization on reports – https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=116764589

The geographical regions mapped in the report are:
1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

North America accounted for the largest share of the global infectious disease diagnostics market. The large share of this region is mainly attributed to the presence of a highly developed healthcare system, increasing prevalence of infectious diseases, the presence of a large number of leading national clinical laboratories, and easy accessibility to technologically advanced instruments in the region.

Some key players mentioned in the research report are:

Abbott Laboratories, Becton, Dickinson and Company, Biomérieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific

Critical questions the report answers:

• Where will all these developments take the industry in the long term?
• What are the upcoming trends for the infectious disease diagnostics market?
• Which segment provides the most opportunity for growth?
• Who are the leading vendors operating in this market?
• What are the opportunities for new market entrants?

Request for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=116764589

Covid 19 Outbreak | Filter Integrity Test Market | Opportunities, Key Players, Competitive and Regional Analysis by Forecast 2024

The growth of the global filter integrity test market is mainly driven by the increasing R&D spending across the globe, growth in the biopharmaceutical industry, and increasing purity requirements.

•  The filter integrity test market is projected to reach USD 79 million by 2024 from USD 59 million in   2018, at a CAGR of 5.0% during the forecast period

Filter Integrity Test Market by Test Type (Bubble Point, Diffusion, Water Flow), Mechanism (Manual, Automation), Filter Type (Air, Liquid), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academics) – Global Forecast to 2024

Market Dynamics :

• Increase in R&D Spending
• Growth in the Biopharmaceutical Industry
• Increasing Purity Requirements in the End-User Market

Download the PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46873904

On the basis of Type

• Diffusion Test
• Bubble Point Test
• Water Flow Integrity Test

On the basis of Filter Type

• Liquid
• Air

On the basis of Mechanism

• Automated
• Manual

On the basis of End user

• Pharmaceutical and Biotechnology Companies
• Contract Manufacturing Organizations
• Other End Users (Research Laboratories and Institutes)

Based on type, the market is segmented into diffusion test, water flow integrity test, and bubble point test. In 2018, the diffusion test segment accounted for the largest share of the filter integrity test market. This segment is also expected to witness the highest growth during the forecast period.

Based on mechanism, the filter integrity test market is segmented into automated and manual filter integrity tests. Integrity tests based on the automated mechanism accounted for the larger share of the market in 2018. In automated integrity testing, the data is not manually entered into the integrity test instrument, which reduces the risk of human error.

Get Sample Report @https://www.marketsandmarkets.com/requestsampleNew.asp?id=46873904

The geographical regions mapped in the report are:

1. North America
2. Europe
3. Asia-Pacific
4. Rest of the World (RoW)

• The market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest share of the market, followed by Europe. The increasing demand for biopharmaceuticals and implementation of drug safety guidelines by the FDA are the major factors driving the growth of the filter integrity test industry in North America.
• The market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period. Significant investments by key market players, increasing government support, developing R&D infrastructure, and growing expertise and academic excellence are the major factors fueling the growth of the market in the Asia Pacific.

For getting 10% customization Please click here @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=46873904

Some key players mentioned in the research report are:

• The major players in the filter integrity test market are Merck KGaA (Germany), Danaher Corporation/Pall Corporation (US), Sartorius (Germany), Donaldson Company (US), Parker Hannifin Corporation (US), Meissner Filtration Product (US), MDI Filtration Technologies (US), Thermo Fisher Scientific (US), Eaton Corporation (Ireland), and SH-Surway (China).
• Merck is another major player in the filter integrity test market. The company has a strong geographic presence across the Americas, Europe, Asia Pacific, and the Middle East and Africa. Merck focuses on inorganic strategies to maintain its leading position in this market

Covid 19 Outbreak | Autoinjectors Market | Opportunities, Key Players, Competitive and Regional Analysis by Forecast 2023

Autoinjectors are used to self-administer drugs for the treatment of various diseases and conditions, such as rheumatoid arthritis, multiple sclerosis, diabetes, and anaphylaxis. Autoinjectors are easy to use, portable, and improve dosing accuracy, making them one of the most popular methods for the self-administration of drugs.

What the Autoinjectors Market Looks Like?

MarketsandMarkets forecasts Autoinjectors market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2%. North America to witness the highest market growth during the forecast period.

Growth in the global autoinjectors market is mainly driven by factors such as the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements in autoinjector devices. The patent expiry of biologics in the coming years is also expected to provide growth opportunities for players in the autoinjectors market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=173991724

What Drives the Autoinjectors Market?

The growth of the global market for Autoinjectors Market is primarily influenced by the following factors:

• Growing Prevalence of Targeted Therapies
• Rising Incidence of Anaphylaxis
• Increasing Number of Regulatory Approvals
• Availability of Generic Versions of Autoinjectors
• Favorable Reimbursements and Government Support
• Technological Advancements and Design Development

Disposable autoinjectors are the most-preferred autoinjectors due to their ease of use and the presence of a built-in glass syringe (eliminates the need for manually loading the glass syringe), which makes it more convenient for patients with reduced dexterity or visual impairments.

A majority of autoinjectors are used for self-administration of drugs and are rarely recommended for hospital use to avoid the risk of infection due to use on multiple patients. This is a major factor in driving the market growth. Other factors such as the growing prevalence of chronic diseases and technological advancements are also boosting this market segment.

Recent Developments :

• In 2018, Abbvie and Samsung Bioepis signed a licensing agreement to launch Humira biosimilar in Europe.
• In 2018, Amgen collaborated with Simcere to co-develop and commercialize biosimilars in China.
• In 2018, Haselmeier partnered with Common Sensing to develop self-monitoring injector platforms, which will help patients to record the time and amount of every dose.
• In 2017, Ypsomed opened a new manufacturing facility in Solothurn (Switzerland). This new facility will focus on the production of injection systems.
• In 2017, Johnson & Johnson received FDA approval of SIMPONI for the treatment of adults with active psoriatic arthritis (PsA) or active ankylosing spondylitis (AS).

Geographical growth scenario of Autoinjectors Market :
The large share of the North American autoinjectors market can primarily be attributed to the rising prevalence of autoimmune and chronic diseases, increasing prevalence of anaphylaxis, and the increasing number of FDA approvals in the region.

Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=173991724

Leading market players and strategies adopted

The prominent players in the Autoinjectors market are SHL Group, Becton Dickinson and Company, Ypsomed, Owen Mumford, Haselmeier

Critical questions the report answers:

• Which are the most significant revenue-generating regions for the market?
• What are the significant upcoming trends in the market?
• How will the market drivers, restraints, and future opportunities affect the market dynamics?
• Which end-user segment is expected to witness maximum growth opportunities during the forecast period?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Healthcare BPO market is estimated to reach $312.43 billion by 2022 grow at a CAGR of 10.2%

In the current market scenario, there is a growing demand for healthcare BPO services. The objective of this report is to define, describe, and forecast the market on the basis of outsourcing services including payer, provider, and pharmaceutical services and region. It provides detailed information regarding the major factors influencing the growth of healthcare outsourcing market.

Healthcare BPO market is estimated to grow at a CAGR of 10.2% from 2017 to 2022 to reach $312.43 billion by 2022 from $191.68 billion in 2017

Healthcare BPO Market by Outsourcing Approaches, Pharmaceutical (R&D, Manufacturing, Sales and Marketing Services (Performance Reporting, Forecasting)), Provider (Patient Care, RCM), Payer (Claims Repricing), Models (Multisourcing) – Global Forecasts to 2022

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=472

Global Healthcare BPO Market  is Segmented on:

1. Outsourcing Approaches, Pharmaceutical
2. Marketing Services
3. Provider
4. Models

Provider

Based on provider services, the Healthcare BPO market is segmented into revenue cycle management, patient enrolment & strategic planning, and patient care. The revenue cycle management segment is expected to grow at the highest CAGR during the forecast period. Growth in the revenue cycle management market can largely be attributed to factors such as decreasing reimbursements in the healthcare industry, reductions in the overall healthcare costs, initiatives undertaken by governments for implementing RCM solutions, and increasing expenditure by the Healthcare IT industry.

Marketing Services

Based on payer services, the Healthcare BPO market is segmented into claims management, integrated front-end services and back-office operations, member management, product development & business acquisition, provider management, care management, billing & accounts management services, and HR services. The product development & business acquisition services segment is expected to grow at the highest CAGR during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=472

The geographical regions mapped in the report are:

• India
• US
• Europe
• Philippines
• China
• LATAM
• Middle East
• RoW

Geographical Growth Analysis:

India possesses lucrative growth potential for the healthcare BPO market, by destination geography during the forecast period. Factors like a mature pharmaceutical and medical education system, large English-speaking population, low-cost base, large talent pool, and diverse set of business process outsourcing (BPO) providers, including local and multinational BPO companies, are driving the market in India.

Some key players mentioned in the research report are:

The key players in the healthcare BPO market are Cognizant (US), Accenture (Ireland), Xerox (US), Genpact (Bermuda), TCS (India), and Infosys (India)

Drug Screening Market (WITH IMPACT OF COVID-19) | Product (Immunoassay Analyzer, Chromatography, Breathalyzer)

According to the new market research report “Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) – Global Forecast ” published by MarketsandMarkets™

Factors such as growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and regulatory approvals and new product & service launches are driving the growth of the market.

What the Market Looks Like?

The drug screening market was valued at USD 4.86 Billion in 2016 and is expected to reach USD 8.63 Billion by 2022, growing at a CAGR of 10.2% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022. The market is dominated by North America, followed by Europe, Asia Pacific, and the Rest of the World (RoW).

The global market by sample type is segmented into urine, breath, oral fluid, hair, and other samples. The urine sample segment is estimated to account for the largest share in 2017, however, the oral fluid samples segment is expected to register the highest growth rate during the forecast period.

Get a sample PDF copy of the Report @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

What Drives the Market?

The growth of the global market for Drug Screening Market is primarily influenced by the following factors:

1 Growing Drug & Alcohol Consumption
2 Enforcement of Stringent Laws Mandating Drug and Alcohol Testing
3 Presence of Government Funding in Major Markets
4 Regulatory Approvals & Product Launches and Services

The study involved four major activities to estimate the current market size for particle therapy. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

The drug screening market is highly competitive with the presence of several big and small players. Prominent players offering products for drug screening include Alere (US), Thermo Fisher (US), Drägerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US). On the other hand, LabCorp (US),etc

Read more about Drug Screening Market @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773